Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history
7:15
Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline in company history
3 months ago
MSNCNBC
Gilead CEO says remdesivir could reach patients within days
5:38
Gilead CEO says remdesivir could reach patients within days
May 3, 2020
CBS NewsMelissa Quinn
Representative Ocasio-Cortez Confronts Gilead CEO Over Truvada Pricing
1:46
Representative Ocasio-Cortez Confronts Gilead CEO Over Truvada Pricing
May 16, 2019
C-SPAN.org
Gilead Sciences: Global Health and Access
Gilead Sciences: Global Health and Access
Sep 17, 2024
gilead.com
'It’s heart-breaking to think that some of us could miss out on this new drug by as little as a few months. Knowing that Trodelvy is there, but women like us may not be able to get access to it is incredibly frightening.' Our amazing Patient Advocates, Philippa, Sophie, Emma, Jo, Nicola, and Lorna have written to Gilead CEO Daniel O’Day, calling on him to guarantee all eligible patients can access the drug Trodelvy, free-of-charge, until a NICE decision about its routine use on the NHS. They are
1:18
'It’s heart-breaking to think that some of us could miss out on this new drug by as little as a few months. Knowing that Trodelvy is there, but women like us may not be able to get access to it is incredibly frightening.' Our amazing Patient Advocates, Philippa, Sophie, Emma, Jo, Nicola, and Lorna have written to Gilead CEO Daniel O’Day, calling on him to guarantee all eligible patients can access the drug Trodelvy, free-of-charge, until a NICE decision about its routine use on the NHS. They are
22.1K viewsOct 12, 2021
FacebookBreast Cancer Now
Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
0:20
Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
1.2K viewsJan 12, 2023
FacebookCNBC
Gilead CEO on drug pricing controversy
4:57
Gilead CEO on drug pricing controversy
Mar 23, 2016
CNBC
1:43
Rep. Ocasio-Cortez on HIV prevention drug: "We the people developed this drug. We paid for this drug...And then that patent has been privatized, despite the fact that the patent is owned by the public...There is no reason this should be $2,000 a month. People are dying because of it." | NBC News
141.7K viewsMay 17, 2019
FacebookNBC News
7:09
Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV
10 months ago
MSNCNBC
1:02
Gilead chairman and CEO Daniel O’Day discusses the company’s new HIV prevention medicine. | CNBC
2.5K viewsJan 13, 2025
FacebookCNBC
1:27
Gilead CEO: Partnerships not limited to oncology
Nov 1, 2016
CNBC
Gilead CEO Daniel O'Day: Ending the HIV epidemic is our goal - The Global Herald
Jan 9, 2023
theglobalherald.com
1:19
Gilead Sciences CEO Daniel O'Day explains why he believes the biopharma's HIV prevention injection Yeztugo, which received approval from the Food and Drug Administration last week, is a "milestone moment" in the history of HIV. Watch more: cnb.cx/3TBo1i1 | CNBC
1.6K views10 months ago
FacebookCNBC
1:13
American taxpayers paid $50 million for the development of a life saving HIV prevention drug. But big pharma corporation Gilead price gouged the drug to the point where people die because they can’t afford it. Thank you Rep. Alexandria Ocasio-Cortez for calling out their horrific greed. | Social Security Works
69.1K viewsMay 16, 2019
FacebookSocial Security Works
6:42
$
Watch CNBC's full interview with Gilead CEO Daniel O'Day
Jan 10, 2022
CNBC
5:17
Watch CNBC's full interview with Gilead CEO Dan O'Day
Jan 13, 2020
CNBC
Balm of Gilead Alternative Clinic CEO wins 2025 Corporate Leadership Excellence Award
Mar 26, 2025
citinewsroom.com
0:51
Guided by our long-standing commitment to the region and the communities we serve, we’re proud of the collective impact our teams make every day, which continue to help shape the Bay Area through scientific innovation, economic contribution and community partnerships. ​ In recognition of that leadership and influence, the San Francisco Business Times named Daniel O’Day, Chairman and CEO, to its Newsmakers 100 list. Gilead congratulates all the SFBT Newsmakers leaders who are shaping the Bay Area
18.5K views2 months ago
FacebookGilead Sciences
1:05
At Gilead, patients are at the heart of everything we do – and we’re focused on developing and delivering innovative therapies across virology, oncology and inflammatory diseases. As we gather today for our annual Science Day, learn why our researchers are passionate about the work they do. #GileadLife | Gilead Sciences
47.4K viewsSep 12, 2024
FacebookGilead Sciences
5:47
$
Watch CNBC's full interview with Gilead CEO Daniel O’Day
Jun 6, 2022
CNBC
0:28
These are Gilead scientists. They’re not just experts in oncology, virology and inflammation: They’re relentless thinkers with an unwavering commitment to discovery. Here, in our labs, every intricate step, reset and do-over plays a critical role in helping set and achieve bold ambitions in our fight against the world’s most devastating diseases. #GileadLife | Gilead Sciences
93.8K views8 months ago
FacebookGilead Sciences
3:46
Gilead CEO Daniel O'Day on acquisition of cancer drugmaker Immunomedics
Sep 14, 2020
CNBC
4:34
Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos
Jul 15, 2019
CNBCMeg Tirrell
4:04
Gilead CEO: We still intend to invest in M&A and our pipeline
Jan 9, 2018
CNBC
4:32
Gilead CEO: Oral version of Covid drug Remdesivir in early testing
Jan 10, 2022
CNBCMeg Tirrell
7:46
Gilead CEO, President Trump, FDA head on authorization for Remdesivir
May 1, 2020
CNBC
5:24
Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV
Jan 13, 2025
CNBCAngelica Peebles
5:59
Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials
Jan 8, 2024
CNBC
6:00
Gilead CEO: M&A is top of mind for us this year
Jan 10, 2017
CNBCMelissa Lee
2:43
Over Gilead’s 35-year history, bold ambitions were set and achieved in the company’s fight against devastating diseases. On our anniversary, watch a video featuring our work to confront the biggest public health challenges of our day for the benefit of generations of people to come. #35YearsofGilead https://gilead.inc/3xH9iXA | Gilead Sciences
300.1K viewsJun 22, 2022
FacebookGilead Sciences
See more